Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (81-90 of 265) with videos related to

Pageof 27
Sort By:
Tumori|January 20, 2025
<i>MLH1</i> promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of <i>MLH1</i> gene?Laura Cazzaniga, Cristina Zanzottera, Sara Mannucci, et al.
Ecancermedicalscience|February 15, 2017
Circulating and tissue biomarkers in early-stage non-small cell lung cancerCaterina Fumagalli, Fabrizio Bianchi, Paola Rafaniello Raviele, et al.
Contemporary Clinical Trials|August 20, 2010
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodologyMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical TrialAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2025
A retrospective study evaluating surgical upstaging rates in low-risk DCIS patients meeting the eligibility criteria for active surveillance trialsJose Vila, Gabriel Farante, Francisco Ripoll-Orts, et al.
Molecules (Basel, Switzerland)|July 1, 2020
Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast TissueMatteo Lazzeroni, Giovanna Petrangolini, José Antonio Legarreta Iriberri, et al.
Clinical Breast Cancer|April 19, 2014
Outcome of male breast cancer: a matched single-institution seriesMonica Iorfida, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasiaBernardo Bonanni, Davide Serrano, Sara Gandini, et al.
International Journal of Cancer|July 7, 2016
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCISAliana Guerrieri-Gonzaga, Ivana Sestak, Matteo Lazzeroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissueLine L Haugan Moi, Marianne Hauglid Flågeng, Sara Gandini, et al.
Pageof 27

Showing results (81-90 of 265) with videos related to

Sort By:
Pageof 27
Tumori|January 20, 2025
<i>MLH1</i> promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of <i>MLH1</i> gene?Laura Cazzaniga, Cristina Zanzottera, Sara Mannucci, et al.
Ecancermedicalscience|February 15, 2017
Circulating and tissue biomarkers in early-stage non-small cell lung cancerCaterina Fumagalli, Fabrizio Bianchi, Paola Rafaniello Raviele, et al.
Contemporary Clinical Trials|August 20, 2010
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodologyMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical TrialAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2025
A retrospective study evaluating surgical upstaging rates in low-risk DCIS patients meeting the eligibility criteria for active surveillance trialsJose Vila, Gabriel Farante, Francisco Ripoll-Orts, et al.
Molecules (Basel, Switzerland)|July 1, 2020
Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast TissueMatteo Lazzeroni, Giovanna Petrangolini, José Antonio Legarreta Iriberri, et al.
Clinical Breast Cancer|April 19, 2014
Outcome of male breast cancer: a matched single-institution seriesMonica Iorfida, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasiaBernardo Bonanni, Davide Serrano, Sara Gandini, et al.
International Journal of Cancer|July 7, 2016
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCISAliana Guerrieri-Gonzaga, Ivana Sestak, Matteo Lazzeroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissueLine L Haugan Moi, Marianne Hauglid Flågeng, Sara Gandini, et al.
Pageof 27